Cowealth Medical China Co.Ltd.

603122.CG▼

Cowealth Medical's first-half net loss widens to 7.5 million yuan

Cowealth Medical released its 2026 interim report, showing its first-half net loss attributable to the parent widened to 7.5 million yuan. Operating revenue was 339 million yuan, down 7.9 percent year on year. Net loss attributable to the parent after deducting non-recurring items was 7.57 million yuan, and net operating cash flow was 14.23 million yuan, down 83.6 percent year on year. The company returned to profit in the second quarter, with net profit attributable to the parent of 790,000 yuan. The company said the operating environment has been affected by national centralized volume-based procurement policies for medical devices and in vitro diagnostic reagents, and the competitive landscape has been deeply reshaped, putting pressure on overall revenue and profitability.

603122.CG ▼

财中社·25dRead more →

603122.CG▼

Hefu China posts first-half net loss attributable to shareholders of about 7.4992 million yuan

Hefu China released its 2026 semi-annual report, showing a first-half net loss attributable to shareholders of about 7.4992 million yuan, compared with a loss of about 7.3382 million yuan in the same period last year. The company achieved first-half operating revenue of about 339 million yuan, down 7.87 percent year on year. Hefu China said the performance change was mainly due to the domestic macro environment and the full implementation of centralized procurement policies in various regions, which led to lower procurement prices for hospital customers and shrinking order volumes, causing revenue from its IVD intensive business to decline year on year. The company continued to invest in iterative research and development of its own ACME products and market expansion, with MetaWei moving from technical validation into clinical use, while also optimizing supply chain management. Operating profit improved, and the decline in performance this period has narrowed significantly compared with the same period last year.

603122.CG ▼

北京商报·25dRead more →

Artificial Intelligence▲

National-level healthcare grassroots strengthening project launched; Cowealth China's ACME platform precisely matches three research directions

The National Health Commission's Capacity Building and Continuing Education Center has launched a research project in Beijing titled "Research on the Application of Intelligent Technologies in Continuing Medical Education," drawing concentrated attention from central and local mainstream media. The project focuses on three dimensions: surgical practice, clinical thinking, and operational management, covering approximately 20 key specialties. It aims to address the practical skills gap among grassroots doctors through a multimodal intelligent training platform that enables remote two-way interaction and real-time operational guidance. As a core participant, Cowealth China's "ACME Empowerment" platform precisely matches the project's three research directions, having formed a corresponding product matrix: A – AI Clinical Specialty Diagnosis and Treatment Assistance Agent, C – Hospital Decision Analysis Integrated Platform, and M – MetaVision Surgical Teaching and Research Platform. Nationwide, an estimated 500 hospitals at various levels will participate in the research in batches, ultimately establishing a collaborative empowerment model linking top-tier tertiary hospitals, enterprises, and grassroots hospitals across the country.

603122.CG ▲

Artificial Intelligence

证券时报·61dRead more →